Back to Rankings

SGMT

Sagimet BiosciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SGMT vs peer average
67/100
SGMT vs. peer average (B vs. C)
Grade spread
B 5 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

REPL is the first available peer comparator.

Small-cap clinical biotech with binary trial and financing sensitivity; useful as an event-risk comp, but indication overlap is loose.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerREPLReplimune Group
SGMT
Sagimet Biosciences
REPL
Replimune Group
Grade
B
D
Momentum
79
99
Value
41
41
Sentiment
63
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs REPL

SGMT / REPL
Grade Position
In line
SGMT vs. peer average (B vs. C)
67/100
Momentum
79
REPL
Value
41
SGMT
Sentiment
63
SGMT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SGMT
1
REPL
REPL
D
40/100
+2
2
FBRX
FBRX
D
40/100
+2
3
ADCT
ADCT
C
60/100
+1
4
PACB
Pacific Biosciences of California Inc Common
D
40/100
+2
5
PBYI
Puma Biotechnology Inc Common
B
80/100
Even
REPL is the first peer returned for this comparison set.